4-1BB ligand signaling to T cells limits T cell activation

Journal of Immunology

Volumn 194, Issue 1, 2015, Pages 134-141

  Eun, So Young ^a   Lee, Seung Woo ^b   Xu, Yanfei ^a   Croft, Michael ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CD137 LIGAND; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; CD137 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LYMPHOCYTE DIFFERENTIATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ADOPTIVE TRANSFER; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; TRANSPLANTATION;

4-1BB LIGAND; ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD137; CELLS, CULTURED; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY;

EID: 84919608883     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401383     Document Type: Article

References (25)

1. Croft, M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9: 271-285.
2. Croft, M., W. Duan, H. Choi, S. Y. Eun, S. Madireddi, and A. Mehta. 2012. TNF superfamily in inflammatory disease: Translating basic insights. Trends Immunol. 33: 144-152.
3. Kwon, B. S., J. C. Hurtado, Z. H. Lee, K. B. Kwack, S. K. Seo, B. K. Choi, B. H. Koller, G. Wolisi, H. E. Broxmeyer, and D. S. Vinay. 2002. Immune responses in 4-1BB (CD137)-deficient mice. J. Immunol. 168: 5483-5490.
4. Lee, S. W., Y. Park, T. So, B. S. Kwon, H. Cheroutre, R. S. Mittler, and M. Croft. 2008. Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nat. Immunol. 9: 917-926.
5. Lee, S. W., Y. Park, S. Y. Eun, S. Madireddi, H. Cheroutre, and M. Croft. 2012. Cutting edge: 4-1BB controls regulatory activity in dendritic cells through promoting optimal expression of retinal dehydrogenase. J. Immunol. 189: 2697-2701.
6. Goodwin, R. G., W. S. Din, T. Davis-Smith, D. M. Anderson, S. D. Gimpel, T. A. Sato, C. R. Maliszewski, C. I. Brannan, N. G. Copeland, N. A. Jenkins, et al. 1993. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol. 23: 2631-2641.
7. Wang, C., G. H. Lin, A. J. McPherson, and T. H.Watts. 2009. Immune regulation by 4-1BB and 4-1BBL: Complexities and challenges. Immunol. Rev. 229: 192-215.
8. Shao, Z., and H. Schwarz. 2011. CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. J. Leukoc. Biol. 89: 21-29.
9. Saito, K., N. Ohara, H. Hotokezaka, S. Fukumoto, K. Yuasa, M. Naito, T. Fujiwara, and K. Nakayama. 2004. Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis. J. Biol. Chem. 279: 13555-13563.
10. Shin, H. H., J. E. Lee, E. A. Lee, B. S. Kwon, and H. S. Choi. 2006. Enhanced osteoclastogenesis in 4-1BB-deficient mice caused by reduced interleukin-10. J. Bone Miner. Res. 21: 1907-1912.
11. Kang, Y. J., S. O. Kim, S. Shimada, M. Otsuka, A. Seit-Nebi, B. S. Kwon, T. H. Watts, and J. Han. 2007. Cell surface 4-1BBL mediates sequential signaling pathways "downstream" of TLR and is required for sustained TNF production in macrophages. Nat. Immunol. 8: 601-609.
12. Schwarz, H., F. J. Blanco, J. Von Kempis, J. Valbracht, and M. Lotz. 1996. ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood 87: 2839-2845.
13. Michel, J., S. Pauly, J. Langstein, P. H. Krammer, and H. Schwarz. 1999. CD137- induced apoptosis is independent of CD95. Immunology 98: 42-46.
14. Kim, W., J. Kim, D. Jung, H. Kim, H. J. Choi, H. R. Cho, and B. Kwon. 2009. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease. Biol. Blood Marrow Transplant. 15: 306-314.
15. Madireddi, S., S. Y. Eun, S. W. Lee, I. Nemcovicová, A. K. Mehta, D. M. Zajonc, N. Nishi, T. Niki, M. Hirashima, and M. Croft. 2014. Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. J. Exp. Med. 211: 1433-1448.
16. Kang, J., S. J. Huddleston, J. M. Fraser, and A. Khoruts. 2008. De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. J. Leukoc. Biol. 83: 1230-1239.
17. Langstein, J., J. Michel, J. Fritsche, M. Kreutz, R. Andreesen, and H. Schwarz. 1998. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol. 160: 2488-2494.
18. Langstein, J., J. Michel, and H. Schwarz. 1999. CD137 induces proliferation and endomitosis in monocytes. Blood 94: 3161-3168.
19. Pauly, S., K. Broll, M. Wittmann, G. Giegerich, and H. Schwarz. 2002. CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers. J. Leukoc. Biol. 72: 35-42.
20. Kim, Y. J., G. Li, and H. E. Broxmeyer. 2002. 4-1BB ligand stimulation enhances myeloid dendritic cell maturation from human umbilical cord blood CD34+ progenitor cells. J. Hematother. Stem Cell Res. 11: 895-903.
21. Lippert, U., K. Zachmann, D. M. Ferrari, H. Schwarz, E. Brunner, A. H. Mahbub-Ul Latif, C. Neumann, and A. Soruri. 2008. CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response. Eur. J. Immunol. 38: 1024-1032.
22. Kim, D. K., S. C. Lee, and H. W. Lee. 2009. CD137 ligand-mediated reverse signals increase cell viability and cytokine expression in murine myeloid cells: Involvement of mTOR/p70S6 kinase and Akt. Eur. J. Immunol. 39: 2617-2628.
23. Shin, H. H., E. A. Lee, S. J. Kim, B. S. Kwon, and H. S. Choi. 2006. A signal through 4-1BB ligand inhibits receptor for activation of nuclear factor-kB ligand (RANKL)-induced osteoclastogenesis by increasing interferon (IFN)-b production. FEBS Lett. 580: 1601-1606.
24. Senthilkumar, R., and H. W. Lee. 2009. CD137L- and RANKL-mediated reverse signals inhibit osteoclastogenesis and T lymphocyte proliferation. Immunobiology 214: 153-161.
25. Lee, S. W., A. T. Vella, B. S. Kwon, and M. Croft. 2005. Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J. Immunol. 174: 6803-6808.